MatthewPBoenteMD

Obstetrics & Gynecology • Saint Cloud, MN

General Gynecology, Gynecologic Oncology

Medical Director, US Medical Affairs Gynecologic Oncology Genentech BioOncology

Join to view full profile

Dr. Boente is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Boente's full profile

Already have an account?

Office
1406 Sixth Avenue North
Saint Cloud, MN 56303
Phone+1 320-255-5621
Is this information wrong?

Education & Training

Rush University Medical CenterResidency, Obstetrics and Gynecology, 1986 - 1990
Rush Medical College of Rush University Medical CenterClass of 1986
Duke University HospitalFellowship, Gynecologic Oncology

Certifications & Licensure

FL State Medical License 2017 - 2019
MN State Medical License 2001 - 2018

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Top MD Consumers Checkbook
Fellow (FACS) American College of Surgeons
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Start of enrollment: 2012 Jun 18
Completed
Phase 3
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer Start of enrollment: 2014 Feb 14
Terminated
Phase 2
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

22 citations
Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218.
Angeles Alvarez Secord, Kirsten Bell Burdett, Kouros Owzar, David Tritchler, Alexander B. Sibley, Yingmiao Liu, Mark D. Starr, J. Chris Brady, Heather A. Lankes, Herbe...> ;Clinical Cancer Research. 2020 Mar 15
14 citations
Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Vivian E. von Gruenigen, Helen Q. Huang, David Cella, Michael A. Zevon, Jason A. Lachance, Joan L. Walker, Ritu Salani, Susan C. Modesitt, Robert T. Morris, William H....> ;Gynecologic Oncology. 2018 Jul 1
237 citations
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
John K. Chan, Mark F. Brady, Richard T. Penson, Helen Huang, Michael J. Birrer, Joan L. Walker, Paul DiSilvestro, Stephen C. Rubin, Lainie P. Martin, Susan A. Davidson...> ;The New England Journal of Medicine. 2016 Feb 24
60 citations
Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study
James S. Ferriss, James J. Java, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Joan L. Walker, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthe...> ;Gynecologic Oncology. 2015 Oct 1
61 citations
Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
Robert A. Burger, Mark F. Brady, Michael A. Bookman, Bradley J. Monk, Joan L. Walker, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew P. Boente, Gini...> ;Journal of Clinical Oncology. 2014 Apr 20
47 citations
Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.
Bradley J. Monk, Helen Q. Huang, Robert A. Burger, Robert S. Mannel, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew P. Boente, Sharon X. Liang, Lari...> ;Gynecologic Oncology. 2013 Mar 1
39 citations
A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261
Keith C. Bible, Prema P. Peethambaram, Ann L. Oberg, William J. Maples, David L. Groteluschen, Matthew P. Boente, Jill K. Burton, Leigh C. Gomez Dahl, Jennifer D. Tibo...> ;Gynecologic Oncology. 2012 Oct 1
1559 citations
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Helen Q. Huang, Robert S. Mannel, Howard D. Homesley, Jeffrey M. Fowler, Benjami...> ;The New England Journal of Medicine. 2011 Dec 28
51 citations
A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a “Sandwich” method for stage III, IV, and recurrent endometrial cancer
Melissa A. Geller, Joseph J. Ivy, Rahel G Ghebre, Levi S. Downs, Patricia L. Judson, Linda F. Carson, Amy L. Jonson, Kathryn E. Dusenbery, Rachel Isaksson Vogel, Matth...> ;Gynecologic Oncology. 2011 Apr 1
55 citations
Growth regulation and transformation of ovarian epithelium
Andrew Berchuck, Matthew F. Kohler, Matthew P. Boente, Gustavo C. Rodriguez, S B S Regina Whitaker, Robert C. Bast> ;Cancer. 2010 Aug 31
Phase III trial of bevacizumab (BEV) in the primary treatment of advanced epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), or fallopian tube cancer (F...
Burger RA, Brady MF, Bookman MA, Walker JL, Homesley HD, Fowler J, Monk BJ, Greer BE, Boente M, Liang SX> ;J. Clin. Oncol.. 2010-06-20
7 citations
Feasibility and morbidity of using saline filled tissue expanders to reduce radiation-induced bowel injury in patients with gynecologic malignancies
Melissa A. Geller, Peter A. Argenta, Sajeena G. Thomas, Kathryn E. Dusenbery, Patricia L. Judson, Matthew P. Boente> ;European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2009 Apr 1
22 citations
A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma.
Levi S. Downs, Patricia L. Judson, Peter A. Argenta, Rahel G Ghebre, Melissa A. Geller, Robin L. Bliss, Matthew P. Boente, William A. Nahhas, Samir Abu-Ghazaleh, M.Dwi...> ;Cancer. 2008 Jan 15
108 citations
Disaggregation and invasion of ovarian carcinoma ascites spheroids
Kathryn M. Burleson, Matthew P. Boente, Stefan E. Pambuccian, Amy P.N. Skubitz> ;Journal of Translational Medicine. 2006 Jan 24
9 citations
Widespread lymph node metastases in a young woman with FIGO stage IA1 squamous cervical cancer.
Peter A. Argenta, Gregory J. Kubicek, Kathryn E. Dusenberry, Patricia L. Judson, Levi S. Downs, Linda F. Carson, Matthew P. Boente> ;Gynecologic Oncology. 2005 May 1
3 citations
Utility and limitations of abdominal radiotherapy in the management of endometrial carcinomas.
Kathryn E. Dusenbery, Roger A. Potish, Douglas G. Gold, Matthew P. Boente> ;Gynecologic Oncology. 2005 Mar 1
9 citations
Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
Kathryn E. Dusenbery, Ellen E. Bellairs, Roger A. Potish, Leo B. Twiggs, Matthew P. Boente> ;Gynecologic Oncology. 2005 Feb 1
43 citations
Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression
Melissa A. Geller, Peter A. Argenta, William H. Bradley, Kathryn E. Dusenbery, Doris C. Brooker, Levi S. Downs, Patricia L. Judson, Linda F. Carson, Matthew P. Boente> ;Gynecologic Oncology. 2004 Dec 1
4 citations
A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer
Levi S. Downs, Patricia L. Judson, Peter A. Argenta, Linda F. Carson, Matthew P. Boente> ;Gynecologic Oncology. 2004 Nov 1
36 citations
Hysteroscopy and cytology in endometrial cancer.
William H. Bradley, Matthew P. Boente, Doris C. Brooker, Peter A. Argenta, Levi S. Downs, Patricia L. Judson, Linda F. Carson> ;Obstetrics and Gynecology. 2004 Nov 1
54 citations
A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy.
Patricia L. Judson, Amy L. Jonson, Pamela J. Paley, Robin L. Bliss, Karuna P. Murray, Levi S. Downs, Matthew P. Boente, Peter A. Argenta, Linda F. Carson> ;Gynecologic Oncology. 2004 Oct 1
3 citations
A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian cancer
Patricia L. Judson, C Blair Harkness, Matthew P. Boente, Levi S. Downs, Peter A. Argenta, Linda F. Carson> ;Gynecologic Oncology. 2004 Jun 1
59 citations
Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer.
Patricia L. Judson, Melissa A. Geller, Robin L. Bliss, Matthew P. Boente, Levi S. Downs, Peter A. Argenta, Linda F. Carson> ;Gynecologic Oncology. 2003 Nov 1
17 citations
Phase I Trial of Multiple Cycles of High-Dose Carboplatin, Paclitaxel, and Topotecan With Peripheral-Blood Stem-Cell Support as Front-Line Therapy
Russell J. Schilder, James M. Gallo, Michael Millenson, Michael A. Bookman, Louis M. Weiner, Andre Rogatko, Barbara B. Rogers, Kristin Padavic-Shallers, Matthew P. Boe...> ;Journal of Clinical Oncology. 2001 Feb 15
21 citations
Phase I Trial of Multiple Cycles of High-Dose Chemotherapy Supported by Autologous Peripheral-Blood Stem Cells
Russell J. Schilder, Steven W. Johnson, James M. Gallo, Scott Kindsfather, Barbara B. Rogers, Michael A. Bookman, Michael Millenson, Matthew P. Boente, Norman G. Rosen...> ;Journal of Clinical Oncology. 1999 Jul 1
Join now to see all

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow
American College of Surgeons - ACS
Member

Hospital Affiliations

Abbott Northwestern HospitalMinneapolis, Minnesota
M Health Fairview Southdale HospitalMinneapolis, Minnesota